NCT02984085 Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB. Status TERMINATED Phase PHASE1/PHASE2
NCT02698735 Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients Status COMPLETED Phase PHASE1/PHASE2
NCT02493816 Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa Status COMPLETED Phase PHASE1
NCT02323789 Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa Status UNKNOWN Phase PHASE1/PHASE2
NCT01874769 Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) Status COMPLETED Phase N/A